Skip to main content
. 2023 Mar 27;15(3):321–352. doi: 10.4254/wjh.v15.i3.321

Table 1.

Screening protocols proposal for the surveillance of de novo neoplasms in liver transplantation population

Malignancy Screening proposal
Skin cancer Annual dermatological visit[4], shorter follow up interval for high risk patients (i.e. every six months)
Lung cancer Annual thoracic X-Ray; CT-scan in active or past smokers[282]
Colorectal cancer Perform baseline colonoscopy on patients > 50 years old; annual fecal occult blood test in younger patients or if colonoscopy is negative; annual colonoscopy if patient affected by PSC + inflammatory bowel disease[1]
Ear, nose, and throat cancers Annual otolaryngological visit in patient with active or past alcohol and/or smoking habit[124]
Renal cancer Annual abdominal ultrasound
Cervical cancer Annual papanicolau-test; annual gynecological visit
Breast cancer Annual mammography, ultrasound evaluation if needed
Prostate cancer Annual PSA and PSA ratio evaluation

CT: Computed tomography; PSC: Primary sclerosing cholangitis; PSA: Prostate specific antigen.